blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2326350

EP2326350 - COMPOUNDS FOR KILLING PSMA-EXPRESSING, TAXANE-RESISTANT CANCER CELLS [Right-click to bookmark this link]
Former [2011/22]METHODS FOR KILLING PSMA-EXPRESSING, TAXANE-RESISTANT CANCER CELLS
[2013/15]
StatusNo opposition filed within time limit
Status updated on  11.07.2014
Database last updated on 01.01.2025
Most recent event   Tooltip24.07.2015Lapse of the patent in a contracting state
New state(s): BG		published on 26.08.2015  [2015/35]
Applicant(s)For all designated states
Psma Development Company, L.L.C.
777 Old Saw Mill River Road
Tarrytown, New York 10591 / US
[2011/22]
Inventor(s)01 / MA, Dangshe
49 Glenwood Road
Millwood NY 10546 / US
02 / OLSON, William, C.
815 Locke Lane
Yorktown Heights NY 10591 / US
03 / MORRIS, Stephen
115 North Highland Place
Croton on Hudson
NY 10520 / US
04 / ISRAEL, Robert
50 Oxford Drive
Suffern NY 10901 / US
 [2013/36]
Former [2011/22]01 / MA, Dangshe
49 Glenwood Road
Millwood NY 10546 / US
02 / OLSON, William, C.
815 Locke Lane
Yorktown Heights NY 10591 / US
03 / MORRIS, Stephen
115 North Highland Place Croton on Hudson
NY 10520 / US
04 / ISRAEL, Robert
50 Oxford Drive
Suffern NY 10901 / US
Representative(s)Jump, Timothy John Simon, et al
Venner Shipley LLP
200 Aldersgate
London EC1A 4HD / GB
[2013/36]
Former [2011/22]Jump, Timothy John Simon, et al
Venner Shipley LLP 20 Little Britain London
EC1A 7DH / GB
Application number, filing date09789284.808.09.2009
[2011/22]
WO2009US05064
Priority number, dateUS20090205395P20.01.2009         Original published format: US 205395 P
US20080095300P08.09.2008         Original published format: US 95300 P
[2011/22]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010027513
Date:11.03.2010
Language:EN
[2010/10]
Type: A2 Application without search report 
No.:EP2326350
Date:01.06.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 11.03.2010 takes the place of the publication of the European patent application.
[2011/22]
Type: B1 Patent specification 
No.:EP2326350
Date:04.09.2013
Language:EN
[2013/36]
Search report(s)International search report - published on:EP10.06.2010
ClassificationIPC:A61K47/48, A61P35/00
[2011/22]
CPC:
A61K47/6811 (EP,US); A61K47/6869 (EP,US); A61P35/00 (EP);
A61P35/04 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/22]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:VERBINDUNGEN ZUR TÖTUNG VON PSMA-EXPRIEMIERENDEN UND TAXANE-RESISTENTEN KREBSZELLEN[2013/15]
English:COMPOUNDS FOR KILLING PSMA-EXPRESSING, TAXANE-RESISTANT CANCER CELLS[2013/15]
French:COMPOSÉS POUR TUER DES CELLULES CANCÉREUSES EXPRIMANT PSMA ET RÉSISTANTES AU TAXANE[2013/15]
Former [2011/22]VERFAHREN ZUR ABTÖTUNG VON PSMA-EXPRIMIERENDEN TAXAN-RESISTENTEN KREBSZELLEN
Former [2011/22]METHODS FOR KILLING PSMA-EXPRESSING, TAXANE-RESISTANT CANCER CELLS
Former [2011/22]PROCÉDÉS POUR TUER DES CELLULES CANCÉREUSES EXPRIMANT PSMA ET RÉSISTANTES AU TAXANE
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase09.03.2011National basic fee paid 
09.03.2011Designation fee(s) paid 
09.03.2011Examination fee paid 
Examination procedure09.03.2011Examination requested  [2011/22]
27.05.2011Amendment by applicant (claims and/or description)
15.03.2013Communication of intention to grant the patent
23.07.2013Fee for grant paid
23.07.2013Fee for publishing/printing paid
Divisional application(s)EP13182516.8  / EP2727606
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.03.2013
Opposition(s)05.06.2014No opposition filed within time limit [2014/33]
Fees paidRenewal fee
26.09.2011Renewal fee patent year 03
25.09.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG04.09.2013
CY04.09.2013
EE04.09.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
MK04.09.2013
MT04.09.2013
RO04.09.2013
SI04.09.2013
SK04.09.2013
SM04.09.2013
IS04.01.2014
[2015/35]
Former [2015/32]CY04.09.2013
EE04.09.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
MK04.09.2013
MT04.09.2013
RO04.09.2013
SI04.09.2013
SK04.09.2013
SM04.09.2013
IS04.01.2014
Former [2015/24]CY04.09.2013
EE04.09.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
RO04.09.2013
SI04.09.2013
SK04.09.2013
SM04.09.2013
IS04.01.2014
Former [2014/29]CY04.09.2013
EE04.09.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
RO04.09.2013
SI04.09.2013
SK04.09.2013
IS04.01.2014
Former [2014/23]CY04.09.2013
EE04.09.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
RO04.09.2013
SI04.09.2013
SK04.09.2013
IS04.01.2014
Former [2014/22]CY04.09.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
RO04.09.2013
SI04.09.2013
Former [2014/18]CY04.09.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
SI04.09.2013
Former [2014/12]CY17.07.2013
HR04.09.2013
LT04.09.2013
LV04.09.2013
SI04.09.2013
Former [2014/10]CY17.07.2013
HR04.09.2013
LT04.09.2013
Former [2014/09]HR04.09.2013
LT04.09.2013
Former [2014/08]LT04.09.2013
Cited inInternational search[A]US6136311  (BANDER NEIL H [US]) [A] 1-116 * Sequences 3-5; claims *;
 [A]WO2007002222  (PSMA DEV COMPANY LLC [US], et al) [A] 1-116 * Claims *;
 [A]  - MATTHEW D GALSKY ET AL, "Phase I Trial of the Prostate-Specific Membrane Antigen Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US LNKD- DOI:10.1200/JCO.2007.15.0532, vol. 26, no. 13, ISSN 0732-183X, (20080501), pages 2147 - 2154, (20080324), XP007912415 [A] 1-116 * Abstract, page 2147-page 2148 third paragraph *

DOI:   http://dx.doi.org/10.1200/JCO.2007.15.0532
 [T]  - KATI K WALTERING ET AL, "Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD., US LNKD- DOI:10.1158/0008-5472.CAN-09-0919, (20091015), vol. 69, no. 20, ISSN 0008-5472, pages 8141 - 8149, XP007912416 [T] * abstract; page 8141 first paragraph *

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-09-0919
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.